VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System
Financing led by Petrichor strengthens VERO Biotech’s position as a leader in neonatal intensive care VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute…
Read More